Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesEvidence-based management of ANCA vasculitis
Best Practice & Research: Clinical Rheumatology, 06/29/09
Carruthers D et al. - Treatment strategies for these primary inflammatory vascular diseases have varied based on the outcomes of different clinical trials and practice reviews. The individual drugs used and their route of administration, dose, and duration of therapy have varied and have been the source of much debate. Advances in the understanding of disease immunopathogenesis, clinical assessment and outcome have formed the basis for several recent good-quality clinical trials.
Today in Vasculitic Syndromes...keeping you current
Receive free subspecialty "5-minute updates" via email
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçets disease refractory to standard immunosuppressive drugs
Rheumatology International, 10/30/09
Vasculitis in Children and Adolescents: Clinical Presentation, Etiopathogenesis, and Treatment
Pediatric Drugs, 11/11/09
Update in paediatric vasculitis
Best Practice & Research: Clinical Rheumatology, 10/27/09
Sponsor
Article Search
Sponsor